Profil
Sebastian A. Meier-Ewert is the founder.
At GPC Biotech AG, held the title of Chief Scientific Officer & Senior Vice President from 1997 to 2009.
At iOmx Therapeutics AG, held the title of Chief Executive Officer.
At ROSCUE Therapeutics GmbH, holds the title of Chief Executive Officer since 2020.
Dr. Meier-Ewert is also the founder of Prosalix GmbH.
Current job includes Chief Operating Officer at GPC Biotech, Inc. since 1997.
Former jobs include Director-Supervisory Board at Immatics Biotechnologies GmbH, Managing Director at SAW Instruments GmbH, and Managing Director at KI Kapital GmbH.
Education includes a doctorate from the University of London and an undergraduate degree from University College London.
Postes actifs de Sebastian Meier-Ewert
| Sociétés | Poste | Début |
|---|---|---|
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade Develops anticancer drugs | Directeur des opérations | 01/01/1997 |
Prosalix GmbH | Directeur Général | 19/05/2011 |
Anciens postes connus de Sebastian Meier-Ewert
| Sociétés | Poste | Fin |
|---|---|---|
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs | Fondateur | 02/12/2009 |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Directeur Général | - |
KI Kapital GmbH
KI Kapital GmbH Investment ManagersFinance KI Kapital invests in companies located in Europe. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for later stage capital requirements. | Directeur Général | - |
SAW Instruments GmbH
SAW Instruments GmbH Medical SpecialtiesHealth Technology Designs, develops and sells biosensor-based laboratory instruments | Directeur Général | - |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Directeur/Membre du Conseil | - |
Formation de Sebastian Meier-Ewert
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs | Commercial Services |
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade Develops anticancer drugs | Retail Trade |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Health Technology |
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAW Instruments GmbH
SAW Instruments GmbH Medical SpecialtiesHealth Technology Designs, develops and sells biosensor-based laboratory instruments | Health Technology |
KI Kapital GmbH
KI Kapital GmbH Investment ManagersFinance KI Kapital invests in companies located in Europe. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for later stage capital requirements. | Finance |
Prosalix GmbH | |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Health Technology |
















